StreetAlpha.app
Home › Stocks › COR

Cencora, Inc. (COR)

Healthcare
$350.36
▼ −1.88%
LAST CLOSE · NOV 17

Cencora distributes pharmaceuticals and other healthcare products to pharmacies, healthcare providers and other customers. It last closed at $350.36 on Nov 17, down 1.88% on the day. COR reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 8 analysts is $391.25 (+11.7% from the last close), with a high of $413.00 and a low of $375.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (8 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in COR, 0% of them bullish and 100% bearish. In the past 30 days there were 4 dark pool prints totaling $3.2M, the largest $1.1M.

AI Auto Pilots
Is COR in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$333B
+5.1% vs a year ago
Net income
$2.6B
+38.3% vs a year ago
EPS (diluted)
$13.47
+38.3% vs a year ago
Free cash flow
$4.1B
1.2% margin
Valuation
Market cap
$66.9B
190.8M shares
P/E
26.0
Price over 12 month EPS
Price to sales
0.2
Market cap over revenue
Dividend yield
0.67%
$2.35 a share over 12 months
Balance sheet
Cash & equivalents
$2.8B
At Jun 30
Debt
$11.7B
At Jun 30
Shareholder equity
$3.1B
Shares outstanding
190.8M
At Jul 31
CEOSteven H. Collis
Fiscal year endsSeptember
ExchangeNYSE
Financials history
FY2021: $214B$214BFY2021FY2022: $239B$239BFY2022FY2023: $262B$262BFY2023FY2024: $294B$294BFY2024FY2025: $321B$321BFY2025

From COR's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 5). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$4.53
$90.44B revenue est.
Year-ago EPS
$4.08
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 8 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
8firms
8 Buy0 Hold0 Sell
Each firm's latest rating on COR in the past 90 days
Average 12-month target
$391.25
▲ 11.7% upside

Based on 8 analysts who set a price target on COR in the past 90 days. The average target is $391.25, with a high of $413.00 and a low of $375.00, compared with the last close of $350.36.

Low $375.00Avg $391.25High $413.00
Blue marker: last close $350.36
Highest target$413.00
Average target$391.25
Lowest target$375.00
Latest rating changes
Wells FargoTarget raised
Nov 17Buy$395 → $400
JP MorganTarget raised
Nov 10Buy$390 → $413
Leerink PartnersTarget raised
Nov 5Buy$388 → $405
Evercore ISI GroupTarget raised
Nov 5Buy$350 → $380
Morgan StanleyTarget raised
Oct 30Buy$346 → $377
DateFirmActionRatingPrice target
Nov 17Wells FargoTarget raisedBuy$395 → $400
Nov 10JP MorganTarget raisedBuy$390 → $413
Nov 5Leerink PartnersTarget raisedBuy$388 → $405
Nov 5Evercore ISI GroupTarget raisedBuy$350 → $380
Oct 30Morgan StanleyTarget raisedBuy$346 → $377
Loading…

Technical Analysis

COR · as of the Nov 17 close · updated after every close
Uptrend

The stock is 3% above its 20 day and 6% above its 50 day average. It is 10% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 58). The nearest support is the Pivot S1 at $347.61, and the nearest resistance the Pivot at $352.45.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 2.5%/day
Key levels
$377.5452 week high+7.8%
$363.95Swing high (Nov 5)+3.9%
$355.19Pivot R1+1.4%
$352.45Pivot+0.6%
$350.36Last close
$347.61Pivot S1−0.8%
$340.8720 day average−2.7%
$333.05Swing low (Nov 6)−4.9%
$328.2150 day average−6.3%
$320.54100 day average−8.5%
$316.64200 day average−9.6%
$244.8252 week low−30.1%
Indicators
RSI (14)58.16Middle of its rangeNeutral
MACD7.16Above its signal lineBullish
Stochastic79.0Middle of its rangeNeutral
ADX (14)32.9Trending up
Williams %R-36.1Oversold below −80, overbought above −20Neutral
CCI (20)90.9Oversold below −100, overbought above 100Neutral
Rate of change+2.8%Change over 10 sessionsBullish
ATR (14)$8.77Typical daily range, 2.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for COR

What happened before

See how COR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow COR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How COR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
0
0%
Bearish
2
100%
Date span
Oct 28 – Nov 2
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
4
Notional
$3.2M
Largest print
$1.1M
Loading…

COR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●625 buying vs 615 selling
  • ▼Held by funds -3.0 pts
  • ▲Funds holding +26
  • ▲Superinvestors: 3 added, 2 cut
  • ▲Put/call 0.38 to 0.35
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,3821,356+1.9%
In funds' top 10108+25.0%
Held by funds94.0%97.0%−3.0 pts
New / increased148 / 47796 / 430+18.8%
Reduced / sold out505 / 110620 / 186−23.7%
Put/call ratio0.350.38−7.5%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See COR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

COR Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$1.9B
2.8% of value
Shares outstanding, 12 months
−1.6%
Fewer shares
Last quarter
$1.0B
Jun 2026
Avg price paid, last quarter
$267.72
3.7M shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $1.0B
Sep 2023: $273.7M, average price $187.89Dec 2023: $441.8M, average price $194.03Mar 2024: $54.7M, average price $235.49Jun 2024: $550.0M, average price $217.51Sep 2024: $508.3M, average price $233.21Dec 2024: $459.4M, average price $227.55Mar 2025: $53.6M, average price $245.11Jun 2025: $116K, average price $266.37Sep 2025: $109K, average price $293.27Dec 2025: $98.2M, average price $341.02Mar 2026: $7.0M, average price $353.58Jun 2026: $1.0B, average price $267.72
Sep 2023Jun 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Aug 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COR is in one of them and how their past COR trades turned out.

COR in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered COR in an article yet. Here's the latest on the wider market.

COR Congress Trades

All congress trades →
Trades, 12 months
17
Buys
8
47%
Sells
9
53%
People
5
Last filed Nov 5
Who traded COR · since 2019
Latest 5 filings of 65
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jun 2, 2026Filed Jul 6, 2026
$50K – $100KTraded May 18, 2026Filed Jul 1, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CABuy$1K – $15KJun 2, 2026Jul 6, 202634 d
Donald J TrumpExecutive branchSell$50K – $100KMay 18, 2026Jul 1, 202644 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Cencora

Cencora is a pharmaceutical distributor based in Conshohocken, Pennsylvania. It moves prescription drugs and other healthcare products from drug manufacturers to customers, including retail pharmacies, healthcare providers and health insurers. Most of its customers buy from it on credit, and its operations are shaped by detailed rules on how drugs are tracked and shipped through the supply chain.

Headquarters
Conshohocken, PA
Founded
2001